Bogac Kaynak - University of Helsinki

Emailbogac.kaynakhelsinkifi

Finland

Research activity per year

Fields of Science

317 Pharmacy

Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach
Leigh, R. S., Kaynak, B. L., Ruskoaho, H. & Välimäki, M. J., 28 Mar 2025, In: PLoS One. 20, 3, 14 p., e0320443.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
TAF1 bromodomain inhibition as a candidate epigenetic driver of congenital heart disease
Leigh, R., Välimäki, M., Kaynak, B. & Ruskoaho, H., Jun 2023, In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 1869, 5, 14 p., 166689.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
Cholecystokinin peptide signaling is regulated by a TBX5-MEF2 axis in the heart
Leigh, R. S., Ruskoaho, H. J. & Kaynak, B. L., Feb 2021, In: Peptides. 136, 14 p., 170459.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line
Välimäki, M. J., Leigh, R. S., Kinnunen, S. M., March, A. R., de Sande, A. H., Kinnunen, M., Varjosalo, M., Heinäniemi, M., Kaynak, B. L. & Ruskoaho, H., 18 Mar 2021, In: Stem Cell Research & Therapy. 12, 1, 18 p., 190.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
A novel dual reporter embryonic stem cell line for toxicological assessment of teratogen-induced perturbation of anterior-posterior patterning of the heart
Leigh, R. S., Ruskoaho, H. J. & Kaynak, B. L., Feb 2020, In: Archives of Toxicology. 94, 2, p. 631-645 15 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File

Arrne Koskelon säätiö Bogac Kaynak
Kaynak, B. (Project manager)
Aarne Koskelon säätiö sr
01/02/2025 → 31/01/2027
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)